Impact Factor 4.137 | CiteScore 4.28
More on impact ›
This specialty is devoted to the rapid and efficient publication of authoritative articles relevant to head and neck cancer. With the increasing understanding that head and neck cancer is not one but rather several different diseases, as highlighted by the presence of human papillomavirus in a subgroup of tumors as well as the recent discovery of multiple characteristic “driver” genetic changes for head and neck cancer, we are entering a new era of clinical, translational, and basic research in head and neck cancer.
Future research will be driven by this new molecular understanding of head and neck cancer. Priority will be given to articles taking into account head and neck cancer subtypes and/or biology with the goal of informing personalized head and neck cancer medicine. As a disease and research area, head and neck cancer is marked by the close collaboration of radiation, medical, and surgical oncology - as well as basic, translational, and clinical research.
This section highlights the interplay of biologic knowledge of head and neck cancers with the multidisciplinary treatments. The section appropriately represents these aspects in its published articles, its target audience, as well as its chosen editors and reviewers. Using an innovative and transparent online platform Head and Neck Cancer aspires to become a premier head and neck cancer focused specialty publication spanning preclinical, biomarker, translational, and clinical studies, as well as up-to-date reviews and commentary relevant to head and neck cancer.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Science Citation Index Expanded, CLOCKSS
Head and Neck Cancer welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Head and Neck Cancer, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Head and Neck Cancer will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Oncology.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org